The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High-dose vitamin C to enhance neoadjuvant immune checkpoint therapy in mismatch repair proficient colon cancer: The ALFEO pilot study.
 
Andrea Sartore-Bianchi
Honoraria - Guardant Health
Consulting or Advisory Role - Amgen; Bayer; Novartis; Sanofi; SERVIER
 
Alessio Amatu
No Relationships to Disclose
 
Federica Di Nicolantonio
Speakers' Bureau - Pierre Fabre
 
Teresa Troiani
Consulting or Advisory Role - BMS Italy; Novartis; Pfizer; SERVIER
 
Federica Tosi
No Relationships to Disclose
 
Stefania Napolitano
No Relationships to Disclose
 
Giulia Martini
Honoraria - Incyte; SERVIER
 
Katia Bencardino
No Relationships to Disclose
 
Erica Bonazzina
No Relationships to Disclose
 
Pietro Carnevali
No Relationships to Disclose
 
Edoardo Forti
No Relationships to Disclose
 
Massimo Mutignani
No Relationships to Disclose
 
Angelo Vanzulli
No Relationships to Disclose
 
Silvia Ghezzi
No Relationships to Disclose
 
Francesco Scaglione
No Relationships to Disclose
 
Silvia Marsoni
Consulting or Advisory Role - Axiom Healthcare Strategies; Ellipses Pharma
 
Alberto Bardelli
Stock and Other Ownership Interests - NeoPhore
Honoraria - Guardant Health; Inivata
Consulting or Advisory Role - Inivata; NeoPhore
Research Funding - AstraZeneca; Boehringer Ingelheim; NeoPhore
 
Fortunato Ciardiello
Consulting or Advisory Role - Amgen; Bayer; Merck KGaA; Pfizer; Roche/Genentech
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Roche/Genentech (Inst); SERVIER (Inst); Symphogen (Inst)
 
Giovanni Ferrari
No Relationships to Disclose
 
Salvatore Siena
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; CheckmAb; Clovis Oncology; Daiichi Sankyo; Incyte; Merck; Novartis; Roche/Genentech; Seagen
Research Funding - MSD Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche